97133 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
PROTEINS AND IMMUNIZING COMPOSITIONS CONTAINING PASTEURELLA PROTEINS AND METHODS OF USE
#2Identification of Polynucleotides Associated with a Sample
#3Peptides and antibodies for the removal of biofilms
#4COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCY
#5Identification of Polynucleotides Associated with a Sample
#6Proteins and immunizing compositions containing proteins and methods of use
#7Identification of Polynucleotides Associated with a Sample
#8Compositions and methods for the removal of biofilms
#9DNABII VACCINES AND ANTIBODIES WITH ENHANCED ACTIVITY
#10Compositions and methods for the treatment of immunodeficiency
#11Binding moieties for biofilm remediation
#12Recombinant Polyclonal Proteins and Methods of Use Thereof
#13Compositions and methods for the removal of biofilms
#14Innocuous, structured scaffolds for structure-based amyloid disease vaccines and antigens
#15Peptides and antibodies for the removal of biofilms
#16Proteins and immunizing compositions containing proteins and methods of use
#17Compositions and methods for the treatment of immunodeficiency
#18Sequencing chicken antibody repertoires following hyperimmunization and the identification of antigen-specific monoclonal antibodies
#19BINDING MOLECULES TARGETING PATHOGENS
#20Proteins and immunizing compositions containing pasteurella proteins and methods of use
#21Binding moieties for biofilm remediation
#22Compositions and methods for the removal of biofilms
#23Antibody fragments for the treatment of biofilm-related disorders
#24DNABII vaccines and antibodies with enhanced activity
#25Binding moieties for biofilm remediation
#26ACTINOBACILLUS PLEUROPNEUMONIAE RECOMBINANT TOXIN PROTEIN AND APPLICATION THEREOF
#27Peptides and antibodies for the removal of biofilms
#28Compositions and methods for the treatment of immunodeficiency
#29BINDING MOLECULES TARGETING PATHOGENS
#30Compositions and methods for the treatment of immunodeficiency
#31ANTIBODIES, VARIABLE DOMAINS & CHAINS TAILORED FOR HUMAN USE
#32Immunogen adherence and method of making and using same
#33Emulsified vaccine to obtain formulations of concentrated IgY immunoglobulins; processes and uses for the same
#34type IV pili
#35Method of treating protozoal gastrointestinal disorders in immunocompromised patients
#36GENES OF AN OTITIS MEDIA ISOLATE OF NONTYPEABLE HEAMOPHILUS INFLUENZAE
#37Binding moieties for biofilm remediation
#38COMPOSITIONS AND METHODS FOR THE REMOVAL OF BIOFILMS
#39Compositions and methods for the treatment of immunodeficiency
#40Compositions and methods for the treatment of immunodeficiency
#41HAEMOPHILUS INFLUENZAE TYPE B
#42BINDING MOIETIES FOR BIOFILM REMEDIATION
#43GENES OF AN OTITIS MEDIA ISOLATE OF NONTYPEABLE HEAMOPHILUS INFLUENZAE
#44BINDING MOLECULES TARGETING PATHOGENS
#45Compositions and Methods for the Removal of Biofilms
#46Identification of polynucleotides associated with a sample
#47BINDING MOIETIES FOR BIOFILM REMEDIATION
#48Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities
#49Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
#50Genes of an otitis media isolate of nontypeable
#51GENES OF AN OTITIS MEDIA ISOLATE OF NONTYPEABLE HAEMOPHILUS INFLUENZAE
#52Chimeric vaccine for -induced disease
#53Genes of an otitis media isolate of nontypeable
#54CHEMICALLY PROGRAMMABLE IMMUNITY
#55Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof
#56HAEMOPHILUS INFLUENZAE TYPE B
#57Genes of an otitis media isolate of nontypeable
#58Compositions and methods for the removal of biofilms
#59Method and kit for detecting antibody to avibacterium paragallinarum
#60type IV pili
#61Genes of an otitis media isolate of nontypeable
#62Chimeric vaccine for -induced disease
#63Genes of an otitis media isolate of nontypeable
#64PREVENTION AND TREATMENT OF OTITIS MEDIA USING IgA ENRICHED MILK
#65Chemically programmable immunity
#66PROTEIN D - AN IGD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE
#67Genes of an otitis media isolate of nontypeable
#68Haemophilus Influenzae Type B
#69ANTIBODIES FOR DETECTING MICROORGANISMS
#70VACCINE
#71Mutants of the P4 protein of nontypable with reduced enzymatic activity
#72type IV pili
#73Chimeric vaccine for -induced disease
#74Polypeptide from haemophilus influenzae
#75Haemophilus influenzae BASB206 gene and protein
#76Method for Detecting the Presence of Target Bacteria or a Target Component Carbohydrate Antigen Thereof
#77Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
#78Genes of an otitis media isolate of nontypeable
#79Methods for reducing nasopharyngeal colonization of non-typable with synthetic chimeric fimbrin peptides
#80Methods of producing recombinant protein D
#81Vaccine
#82Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines
#83Methods to make and use antibodies of improved cross-reactivity
#84Mutants of the P4 protein of nontypable with reduced enzymatic activity
#85Polypeptide encoded by a nucleotide sequence of a nontypeable strain of genome
#86Antimultiorganism glycoconjugate vaccine
#87type IV pili
#88lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of infections
#89Immunogen adherence and method of making and using same